Research Assistant Professor
Institute for Healthcare Studies
Division of General Internal Medecine
Northwestern University Feinberg School of Medicine

Institute for Healthcare Studies
Northwestern University
750 North Lakeshore Drive
10th Floor
Chicago, IL 60611

Telephone 312-503-5584
Fax          312-503-2777

Email:  Todd A. Lee

Todd A. Lee, PharmD, PhD is currently a research assistant professor in the Institute for Healthcare Studies and the Division of General Internal Medicine in the Northwestern University Feinberg School of Medicine.  He is also a senior investigator in the Center for Management of Complex Chronic Care (CMC³) at the Hines VA Hospital.  Dr. Lee earned his PharmD from Drake University and his Ph.D. from the Pharmaceutical Outcomes Research and Policy Program at the University of Washington.

Health Economic Interests

Dr. Lee’s primary research interest in the area of health economics is economic evaluations of medical technologies or interventions to better understand the value of these new technologies or interventions.  He has experience with economic evaluations conducted alongside clinical trials as well as developing economic models, including decision-tree and Markov health state models.  Dr. Lee also as experience in evaluating pateint preferences utilizing several different elicitation techniques.

Selected Journal Publications

1.         Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000; 117: 5S-9S.

2.         Lee TA, Sullivan SD, Veenstra DL, Ramsey SD, Steger PJK, Malinverni R, Pleil AM, Williamson T. Economic evaluation of systemic treatments for cytomegalovirus retinitis in AIDS patients. Pharmacoeconomics. 2001; 19(5 Pt 2): 535-50.

3.         Lee TA, Weiss KB. An update on the health economics of asthma and allergy. Curr Opin Allergy Clin Immunol. 2002; 2: 195-200.

4.         Lee TA, Weiss KB. Preference assessment in patients with asthma. Expert Rev Pharmacoeconomics Outcomes Res. 2002; 2(6): 607-618.

5.         Lee TA, Hollingworth W, Sullivan SD. Comparison of directly elicited preferences to preferences derived from the SF-36 in adult asthmatics. Med Decis Making. 2003; 23(4): 323-334.

6.         Lee TA, Drivers CH, Leibman CW. Evaluating the efficiency of treatment in the allergic rhinitis market. J Manag Care Pharm. 2004 Jan-Feb; 10(1 Suppl 1): 3-8.

7.         Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics. 2004; 22(6): 345-361.

8.         Lee TA, Veenstra DL, Iloeje UH, Sullivan SD. Cost of chronic hepatitis B infection in the United States. J Clin Gastroenterol. 2004; 38(10 Suppl 3); S144-S147.

9.         Lee TA, Hacek DM, Stroupe KT, Collins SM, Peterson LR. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization and a cost-effectiveness model. Infect Control Hosp Epidemiol. 2005; 26(1): 39-46.

10.     Pickard AS, Wang Z, Walton SM, Lee TA. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? Health Qual Life Outcomes. 2005; 3(11).

11.     Sullivan SD, Lee TA, Blough DK, Finkelstein JA, Lozano P, Inui TC, Fuhlbrigge AL, Carey VJ, Wagner E, Weiss KB. A multi-site randomized trial of the effects of physician education and organizational change in chronic asthma care: Cost-effectiveness analysis of the Pediatric Asthma Care PORT. Arch Pediatr Adolesc Med. 2005; 159(5): 428-434.

12.     Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemel A, Lee TA, Miravitlles M, Aldington S, Beasly R. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27(1): 188-207.

13.     Rutten-van Mölken M, Lee TA. Economic modeling in COPD. Proc Am Thorac Soc. 2006; 3(7): 630-634.